Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Published October 12, 2016 · Recall initiated: September 2, 2016
Summary
FDA records drug Class III recall D-0006-2017, published October 12, 2016 and initiated September 2, 2016. Recalling firm: Shire; Status: Terminated; Reported quantity: 7,680 bottles (768,000 capsules); Lot: Lot # AF3360B; Exp. 04/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if VYVANSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VYVANSE
- Manufacturer
- Shire
- Distributor
- Nationwide
- Lot
- Lot # AF3360B; Exp. 04/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClaravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules EachOctober 12, 2016
- FDAbuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only,October 12, 2016
- FDATri-Mix 18/1/10 (Papaverine 18mg, Phentolamine 1 mg, Prostaglandin 10 mcg/mL) packaged in 2.5 mL sterileOctober 12, 2016
- FDAPredniSONE Tablets USP, 1 mg, 100-count bottles, Rx only, Distr. by: West-Ward Pharmaceuticals Corp.,October 12, 2016
- FDAMethylcobalamin 5000 mcg/mL Injection, packaged in 1, 2, 3, 4, and 5 mL vials, IM, Rx, The Apothecary ShoppeOctober 12, 2016
- FDAProduct in cans of 4 1/4 oz (111g) and 8 1/4 oz (220g) net weight. Label reading in part as: "Coloso***PULPOOctober 12, 2016
Questions about this recall
Was Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10 recalled?
Yes. FDA published recall D-0006-2017 on October 12, 2016. Reported hazard: Presence of Foreign Tablets/Capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VYVANSE.